Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Throat lozenges

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    16 result(s) found for: Throat lozenges. Displaying page 1 of 1.
    EudraCT Number: 2019-003257-29 Sponsor Protocol Number: 030(Z)WO19176 Start Date*: 2020-02-25
    Sponsor Name:Angelini S.p.A.
    Full Title: Phase IV study comparing the efficacy and safety of Benzydamine hydrochloride 0,3% oromucosal spray and Benzydamine hydrochloride 3 mg lozenges in patients with acute sore throat.
    Medical condition: acute sore throat
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2022-003285-20 Sponsor Protocol Number: 030(Z)MD22061 Start Date*: 2023-03-13
    Sponsor Name:Angelini Pharma S.p.A.
    Full Title: Phase IV study comparing the efficacy and safety of an alcohol-free formulation of 0.15% benzydamine hydrochloride spray and benzydamine hydrochloride 3mg lozenges in paediatric patients (6-12 year...
    Medical condition: acute sore throat
    Disease: Version SOC Term Classification Code Term Level
    23.1 100000004855 10041367 Sore throat LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2008-005059-67 Sponsor Protocol Number: TH0809 Start Date*: 2008-11-04
    Sponsor Name:Reckitt Benckiser Healthcare UK Ltd
    Full Title: A multi-centre, randomised, double blind, placebo-controlled, parallel group, single dose, pilot study of the efficacy of 0.6 mg Amylmetacresol BP (AMC) and 1.2mg 2,4-Dichlorobenzyl alcohol (DCBA) ...
    Medical condition: Sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-002876-15 Sponsor Protocol Number: MCMK0112 Start Date*: 2012-11-23
    Sponsor Name:Cassella-med GmbH & Co KG
    Full Title: A randomised, multi-centre, parallel group, double-blind, placebo- and active-controlled clinical study to assess the efficacy and safety of Octenidine lozenges in the treatment of acute sore throat.
    Medical condition: Acute pharyngitis
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-004423-20 Sponsor Protocol Number: V00498TA301 Start Date*: 2013-01-10
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: STUDY OF EFFICACY AND SAFETY OF V0498 VERSUS PLACEBO IN ACUTE SORE THROAT PAIN
    Medical condition: Acute sore throat
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10049140 Pharyngotonsillitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) LV (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2010-021653-39 Sponsor Protocol Number: 075-A-301 Start Date*: 2010-12-08
    Sponsor Name:Novartis Consumer Health S.A.
    Full Title: A randomized, double-blind, parallel group, single-dose study of the efficacy of lidocaine 8 mg + cetylpyridinium chloride (CPC) 2 mg fixed combination lozenges on sore throat pain intensity compar...
    Medical condition: Sore throat due to upper respiratory tract infection (Planned indication for approval: Local antiseptic and analgesic treatment of sore throat and minor infections of the mouth. Relief of pain as ...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041367 Sore throat LLT
    12.1 10068319 Oropharyngeal pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004375-19 Sponsor Protocol Number: TH0705 Start Date*: 2007-10-26
    Sponsor Name:Reckitt Benckiser Healthcare
    Full Title: A multi-centre, randomised, double-blind, parallel-group, placebo-controlled, multiple dose study of the efficacy of Strepsils original throat lozenges in the relief of sore throat due to upper res...
    Medical condition: Sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-005596-10 Sponsor Protocol Number: TH0817 Start Date*: 2008-12-05
    Sponsor Name:Reckitt Benkiser Healthcare (UK) Ltd
    Full Title: A multi centre, randomised, double blind, placebo-controlled, parallel group, single dose study of the efficacy of two flavour variants of Strepsils throat lozenges in the relief of sore throat due...
    Medical condition: Sore Throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-005095-17 Sponsor Protocol Number: EA041999 Start Date*: 2005-02-10
    Sponsor Name:Engelhard Arzneimittel GmbH & Co. KG
    Full Title: Randomised, double-blind, placebo-controlled, monocentric phase III study on the efficacy and safety of Lidocaine 8 mg Sore Throat Lozenges in patients with moderate to severe acute sore throat not...
    Medical condition: The study will be performed in patients suffering from acute sore throat not necessarily to be treated with antibiotics
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-008265-36 Sponsor Protocol Number: KETOP_C_03968 Start Date*: 2009-05-26
    Sponsor Name:SANOFI-AVENTIS GROUPE
    Full Title: “A randomised, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of two doses of ketoprofen lysinate lozenges (6.25mg and 12.5mg ) in patients with sore throat”
    Medical condition: upper respiratory illness : sore throat
    Disease: Version SOC Term Classification Code Term Level
    9.1 10041367 Sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed) FR (Completed) DE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-005848-10 Sponsor Protocol Number: V00498TA201 Start Date*: 2012-02-06
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg, 35mg) after single administration in acute sore throat pain
    Medical condition: Acute sore throat
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10049140 Pharyngotonsillitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-000278-74 Sponsor Protocol Number: KKL022010 Start Date*: 2011-07-11
    Sponsor Name:KRKA, tovarna zdravil, d. d., Novo mesto
    Full Title: A COMPARATIVE EFFICACY AND SAFETY OF CETYLPYRIDINIUM CHLORIDE 1.0 mg/BENZYDAMINE HYDROCHLORIDE 3 mg FIXED COMBINATION LOZENGES IN SUBJECTS WITH SORE THROAT ASSOCIATED WITH UPPER RESPIRATORY TRACT I...
    Medical condition: Sore throat associated with upper respiratory infections
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10041368 Sore throat NOS LLT
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10068319 Oropharyngeal pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    EudraCT Number: 2010-024045-69 Sponsor Protocol Number: TH1017 Start Date*: 2011-01-11
    Sponsor Name:Reckitt Benckiser Healthcare
    Full Title: A multi centre, randomised, double blind, single dose parallel group, placebo controlled study to investigate the efficacy of Strepsils Plus and Strepsils Extra in the treatment of sore throat due ...
    Medical condition: Sore throat due to upper respiratory tract infection
    Disease: Version SOC Term Classification Code Term Level
    12.1 10041367 sore throat LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-003111-38 Sponsor Protocol Number: 6630-9050-03 Start Date*: 2015-12-30
    Sponsor Name:Medice Arzneimittel Pütter GmbH & Co. KG
    Full Title: A double-blind, randomized, placebo-controlled, parallel-group study comparing safety and efficacy of Dorithricin® lozenges with placebo in the symptomatic treatment of patients with acute pharyngitis
    Medical condition: Acute pharyngitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-003962-24 Sponsor Protocol Number: 6632-9050-04 Start Date*: 2016-12-27
    Sponsor Name:Medice Arzneimittel Pütter GmbH & Co. KG
    Full Title: A multi-centre, randomized, placebo-controlled, double-blind, parallel-group study investigating safety and efficacy of a sore throat lozenge in the symptomatic treatment of patients with acute pha...
    Medical condition: Acute Pharyngitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003588-22 Sponsor Protocol Number: TH0504 Start Date*: 2005-11-29
    Sponsor Name:Boots Healthcare International Limited
    Full Title: A single centre, randomised, single (patient) blind, single dose, parallel group exploratory study to compare the efficacy of an 8.75mg flurbiprofen lozenge (Strefen) with a 3mg benzydamine lozenge...
    Medical condition: Sore throat suitable for treatment in an OTC setting.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 15:11:55 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA